Related Experiment Video
Updated: Aug 9, 2025
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.5K
Medulloblastoma: From TP53 Mutations to Molecular Classification and Liquid Biopsy
Robert H Eibl1, Markus Schneemann2
1c/o M. Schneemann; Department of Internal Medicine, Hospitals of Schaffhausen, 8208 Schaffhausen, Switzerland.
Biology
|February 25, 2023
Summary
Medulloblastoma diagnostics now use molecular classification for better prognosis and targeted therapies. This approach enables real-time tumor monitoring and treatment response assessment via liquid biopsy.
Area of Science:
- Neuro-oncology
- Genomics
- Molecular Diagnostics
Background:
- Medulloblastoma diagnosis historically relied on histology.
- Traditional treatments include surgery, radiotherapy, and chemotherapy.
- Controversies exist regarding cell of origin and animal models.
Purpose of the Study:
- To review the paradigm shift in medulloblastoma diagnostics.
- To highlight the impact of molecular classification on prognosis and treatment.
- To discuss the role of liquid biopsy in monitoring tumor development and treatment response.
Main Methods:
- Review of recent developments in medulloblastoma research.
- Analysis of molecular classification based on genetic data.
- Evaluation of liquid biopsy techniques for real-time monitoring.
Main Results:
- Four major medulloblastoma groups identified by genetic data.
- Molecular classification shows improved correlation with prognosis.
- Liquid biopsy offers a new method for monitoring tumor progression and treatment efficacy.
Conclusions:
- The new molecular classification refines medulloblastoma diagnosis and prognosis.
- Targeted therapies can be better managed using genetic data.
- Sequential liquid biopsy represents a significant advancement in real-time monitoring.
Related Concept Videos
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
01:12Loss of Tumor Suppressor Gene Functions
5.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.0K